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Abstract
Background: Human Papillomavirus (HPV) detection results comparing paraffin embedded cervical tissue and
other cervical specimens have been done with varying degrees of agreement. However, studies comparing freshly
frozen specimens and paraffin embedded specimens of invasive cervical carcinomas are lacking. The aim of the
study was to compare HPV detection using SPF10 broad-spectrum primers PCR followed by DEIA and genotyping
by LiPA25 (version 1) between freshly frozen cervical tissue samples and paraffin embedded blocks of cervical tissue
from the same patient. There were 171 pairs of paraffin embedded and freshly frozen samples analyzed from
cervical carcinoma cases from Kampala, Uganda.
Results: 88.9% (95% CI: 83.2%-93.2%) of paraffin embedded samples were HPV positive compared with 90.1% (95%
CI: 84.6%-94.1%) of freshly frozen samples, giving an overall agreement in HPV detection between fresh tissue and
paraffin embedded tissue at 86.0% (95% CI: 79.8%-90.8%). Although the proportion of HPV positive cases in freshly
frozen tissue was higher than those in paraffin blocks, the difference was not statistically significant (p > 0.05). In
both types of tissues, single HPV infections were predominant, with HPV16 accounting for 47% of positive cases.
Comparison in the overall agreement, taking into accounts not only positivity in general, but also HPV types,
showed a 65% agreement (complete agreement of 59.7%, partial agreement of 5.3%) and complete disagreement
of 35.0%. HPV detection in squamous cell carcinomas (SCC) and adenocarcinomas (ADC) was similar in fresh tissue
or paraffin blocks (p ≥ 0.05).
p16 immunostaining in samples that had at least one HPV negative results showed that 24 out of 25 cases had an
over-expressed pattern.
Conclusions: HPV DNA detection was lower among ADC as compared to SCC. However, such differences were
minimized when additional p16 testing was added, suggesting that the technical issues may largely explain the
HPV negative cases.
Background
Improved DNA retrieval methods have made possible the
realization of gene analyses and viral genome identifica-
tion in archival formalin fixed paraffin embedded (FFPE)
tissues [1-4]. A number of methods have been developed
over the past few years to detect the Human Papilloma-
virus (HPV), one of them being Short PCR Fragment-10
(SPF10) Line Probe Assay system (LiPA) [5,6]. This assay
is based on the amplification of a 65-bp region of L1
open reading frame. In order to validate the SPF10 LiPA
assay using FFPE cervical samples, comparisons with
other samples have been performed by some investiga-
tors [7,8] with good overall agreement. The overall agree-
ment was generally high from these studies, when
cervical scrapes or cytological samples were used. Besides
the generally lower detection of HPV in FFPE samples of
cervical carcinoma, it has been shown that adenocarcino-
mas show an even lower positive rate compared to other
histological types [9]. In view of these discrepancies, we
thought it worthwhile to conduct a study to clarify
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any medium, provided the original work is properly cited.whether the formalin fixation could differentially affect
HPV detection according to the histological diagnosis.
The main objective of the present study was to compare
HPV detection using SPF10 broad-spectrum primers
Polymerase Chain Reaction (PCR) followed by Deoxyri-
bonucleic Acid Enzyme Immunoassay (DEIA) and geno-
typing by LiPA25 (version 1) between fresh cervical tissue
samples and paraffin embedded blocks from the same
patients, and also to assess whether there are differences
in HPV detection between squamous cell carcinomas and
adenocarcinomas.
Methods
The materials for this study were obtained as part of a
case-control study conducted at Mulago Hospital, Kam-
pala, Uganda which is the teaching hospital for the Col-
lege of Health Sciences of Makerere University from
September 2004 to December 2006. Tumour specimens
were obtained from new incident cases of cervical carci-
noma presented to the hospital as part of routine care.
The tumour specimens were divided into two parts.
One part was fixed in 10% formalin and entered in the
register of Department of Pathology for processing (par-
affin blocks), while the other part was stored at -80°C
until transferred to the laboratory for analysis. In cases
where the tissue was deemed to be very small, the
whole tissue was formalin fixed and processed for histo-
pathological diagnosis. Each case was given an identifi-
cation number so that the paraffin block could be linked
with the fresh specimen. The samples from the cases
were all biopsies. The local histopathological diagnosis
was performed by Michael Odida.
HPV detection of cervical cancer cases in freshly frozen
tissue
HPV detection and genotyping in 195 freshly frozen cer-
vical cancer specimens was performed at the DDL Diag-
nostic Laboratory in The Netherlands during the period
from June to August 2008, also 1,5 up to 4 years after
diagnosis. HPV detection was performed using SPF10
broad-spectrum primers PCR followed by DEIA and
genotyping by LiPA25 (version 1).
HPV detection of cervical cancer cases preserved in
paraffin
The paraffin embedded blocks were prepared in Uganda
for diagnostics purposes between September 2004 and
December 2006 when the patients were recruited for the
study. HPV detection and genotyping of 201 paraffin
blocks was performed by pathologists at the Unit of Infec-
tions and Cancer at the Catalan Institute of Oncology
(ICO) during January 2010, also 3 to 5.5 years after diag-
nosis. The detailed methods have been previously
described in Odida et al. [10]. Briefly, at ICO the samples
were processed following the next steps: (a) Re-embedding
of the tissue material was done if necessary when the
paraffin block was in poor condition for cutting; (b)
Microtome sectioning of the specimens under non-
contamination conditions and the sandwich technique
were carried out to confirm an optimal number of sections
to be used for DNA extraction and testing; (c) All cases
were reviewed by a trained pathologist at ICO for diagno-
sis and assessing quality of the specimen before HPV test-
ing. Cases difficult to classify, cases with a discordant
diagnosis compared to the field diagnosis and all the rare
histological types were further reviewed by two senior
expert pathologists at ICO; (d) DNA was extracted under
non-contamination protocols and aliquoted, and HPV
testing was performed on each specimen using the SPF-10
broad spectrum primers PCR followed by DEIA. HPV
DNA positive samples were subsequently analyzed by
LiPA25 (version 1: produced at Laboratory Biomedical Pro-
ducts, Rijswijk, The Netherlands), a reverse hybridization
technique that detects 25 high-risk (HR) and low-risk (LR)
HPV types (6, 11, 16, 18, 31, 33, 34, 35, 39, 40, 42, 43, 44,
45, 51, 52, 53, 54, 56, 58, 59, 66, 68, 70, 74). Both labs,
DDL and ICO, performed routine cross-validation testing
for SPF10, DEIA and LiPA with high agreement between
them, concordant results of >98% (data not shown).
Since the number of samples received at DDL and
ICO differ, the comparison was performed based on
the cases that were HPV analyzed in both laboratories,
n = 171. Data generated at Makerere Hospital (original
pathological diagnosis), at DDL (HPV detection in
freshly frozen tissue) and at ICO (pathological diagnosis
and HPV detection in paraffin blocks) were merged
into one dataset using the common identifier first
provided by Makerere University. A descriptive analysis
of global HPV positivity and HPV types globally and by
histological diagnosis of cervical carcinoma and type of
specimens was performed. Global HPV detection con-
cordance analysis, in terms of positive or negative result
was done to assess differences between the fresh and
paraffin, as well as between squamous cell carcinoma
(SCC) and adenocarcinomas (ADC).
Further analysis for the overall agreement, taking into
account not only general positivity but also HPV types,
was done to assess the exact agreement between the
two samples. The agreement was classified as complete,
partial or complete disagreement according to the defi-
nitions below.
Complete agreement
The result is exactly the same (same HPV single type, or
same multiple types or HPV negative result).
Partial agreement
The cases have at least one identical type.
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The cases are totally different (different type or HPV
positive-HPV negative).
p16 Immunohistochemistry
It has been largely described that p16 over-expression is
a surrogate marker of HPV E7 oncoprotein-mediated
catabolism of pRb in premalignant and malignant
lesions of the cervical mucosa. In the present study, p16
immunostaining was performed in a selected number of
paraffin embedded tissue from cancer cases in order (1)
to obtain more insight regarding the HPV oncogenic
role in the discordant cases and (2) to discard non-HPV
related cancers in the concordant HPV negative cases.
The cases included in this analysis were all HPV discor-
dant cases (n = 24), all concordant HPV negative cases
(n = 6) and a random sample of approximately a 10% of
the concordant HPV positive cases (n = 15). p16INK4a
was detected using the CINtec histology kit (clone
E6H4, MTM Laboratories, Heidelberg, Germany), fol-
lowing the manufacturer’s protocol. In each series, a
negative control, and a positive control consisting of an
invasive cervical carcinoma were included. The percen-
t a g eo fs t a i n e dc e l l s( - :<5 % ;+ :5 - 2 5 % ;+ + :2 6 - 7 5 % ;
+++: > 75%) and the pattern (focal/diffuse) was recorded,
and a positive case was considered when the percentage
was 5 and above (++ or more) with a diffuse pattern.
Statistical tests
The Kappa statistics and McNemar test were used to
test the statistical significance of HPV detection between
fresh samples and paraffin blocks, while the Chi square
test and Fisher exact test were used to test the statistical
significance of HPV detection between SCC and ADC in
both fresh and paraffin blocks. Where appropriate, 95%
confidence intervals (CI) were computed, and the level
of statistical significant test was set at 0.05.
Results
Overall agreement between fresh tissue specimens and
paraffin embedded tissue
O v e r a l l ,1 5 4o ff r e s h l yf r o z e nt i s s u ew e r ep o s i t i v ef o r
HPV (90.1%, 95% CI: 84.6%-94.1%) and 152 of tissue in
paraffin blocks were HPV positive (88.9%, 95% CI:
83.2%-93.2%), giving an overall agreement in HPV
detection between fresh tissue and paraffin blocks at
86.0% (95% CI: 79.8%-90.8%), which was statistically sig-
nificant (Kappa Index = 0.26, p = 0.001). Although the
proportion of HPV positive cases in fresh tissue was
higher than those in paraffin blocks, the difference was
not statistically significant (McNemar test, p > 0.05).
The details are shown in Table 1.
In both types of tissues, single HPV infections were
predominant. Only one case has been DEIA positive,
and LiPA negative (HPVX, unknown type) and has been
detected in paraffin embedded tissue. The proportion of
multiple HPV infections was higher in freshly frozen tis-
sue cases than tissue in paraffin blocks. However, the
differences between both kinds of tissues were not stati-
cally significant (all p-values are > 0.05). The details are
shown in Table 2.
HPV types in single infections
In both kinds of tissue, HPV16 was the most frequently
identified in 47.4% among HPV positive cases. The pro-
portion of HPV33, HPV52 and HPV58 were almost
identical. A higher proportion of HPV18 and HPV35
were identified in paraffin blocks compared to fresh tis-
sue and, conversely, a higher proportion of HPV45,
HPV68 or 73, HPV51 and HPV39 in fresh tissue. HPVs
66 and 31 were only identified in fresh tissue and HPVs
59, 11 and HPVX were only detected in paraffin
embedded tissue. The details are shown in Figure 1.
HPV types in multiple infections
Table 3 shows HPV type distribution of multiple types
in freshly frozen tissue versus tissue in paraffin blocks.
In 11 out of the 16 cases described in table 4, the HPV
result matched at least for one of the HPV types.
HPV types agreement between fresh tissue specimens
and paraffin embedded specimens
When analyzed for the overall agreement, also taking
into account HPV types, complete agreement was found
to be 59.7% (complete agreement in single HPV types:
55.0%, complete agreement in multiple types: 1.2%,
complete agreement in HPV negativity: 3.5%), partial
agreement: 5.3% and complete disagreement: 35.0%.
HPV detection concordance by histological type of
cervical carcinoma
For performing the HPV detection concordance analysis
stratified by histological diagnosis, we selected the cases
that had a concordant histological diagnosis between the
Table 1 HPV detection in fresh tissue versus paraffin
block
Paraffin block Total
Positive Negative
N%
a N%
a N%
a
Fresh tissue Positive 141 82.5
b 13 7.6 154 90.1
Negative 11 6.4 6 3.5
b 17 9.9
Total 152 88.9 19 11.1 171 100
a Percentage of cell number among all the cases (171)
b Concordant results
Concordance analysis-Kappa Index: value of the index 0.26; p = 0.001
McNemar test: p > 0.05
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ADC (n = 7).
Sqamous cell carcinoma
T h eH P Vp o s i t i v i t yi nf r e s h l yf r o z e nt i s s u ew a s9 1 . 5 %
(95% CI: 85.4%-95.7%), and the corresponding HPV
positivity in paraffin embedded tissue was 93.1% (95%
CI: 87.3%-96.8%), giving an overall agreement in HPV
detection between fresh tissue and paraffin embedded
tissue of 90.8% (95% CI: 84.4%-95.1%), which was statis-
tically significant, although the strength of concordance
is weak (Kappa Index of agreement of 0.35; p < 0.001).
Although identifying a higher HPV positivity in tissue
from paraffin blocks, this difference was not statistically
significant (McNemar test, p > 0.05).
Adenocarcinoma
The HPV positivity in freshly frozen tissue was 85.7%
(95% CI: 42.1%-99.6%), and the HPV positivity in paraffin
embedded tissue was 71.4% (95% CI: 29.0%-96.3%), giving
an overall agreement in HPV detection between fresh tis-
sue and paraffin blocks: 85.7% (95% CI: 42.1%-99.6%),
which was not statistically significant (Kappa Index of
agreement of 0.59; p > 0.05). Although identifying a
higher HPV positivity in fresh tissue, this difference was
not statistically significant (McNemar test, p > 0.05).
HPV detection concordance between histological types of
cervical carcinoma
Comparing HPV positivity by diagnosis and tissue pre-
servation, adenocarcinomas were more likely to be HPV
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Figure 1 HPV type distribution of single types in fresh tissue versus paraffin block. Percentiles (%) of single/multiple/X HPV types among
HPV positive cases.
Table 2 HPV detection in fresh tissue versus paraffin block: single/multiple/HPVX types
HPV detection Fresh tissue Paraffin block
Number of cases % 95% CI
b Number of cases % 95% CI
b
Cases HPV analyzed 171 100 171 100
HPV negative 17 9.9 (5.9-15.4) 19 11.1 (6.8-16.8)
HPV positive 154 90.1 (84.6-94.1) 152 88.9 (83.2-93.2)
Single HPV types
a 143 92.9 (87.6-96.4) 144 94.7 (89.9-97.7)
Multiple HPV types
a 11 7.1 (3.6-12.4) 7 4.6 (1.9-9.3)
HPV X - unknown
a 0 0.0 (0.0-2.4) 1 0.7 (0.0-3.6)
CI, Confidence Interval;
a Number of single/multiple/X among HPV positive cases;
b For all comparisons: p-value > 0.05
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paraffin embedded tissue. This difference was higher in
paraffin embedded tissue than in fresh tissue (21 per-
centage points difference versus 6, respectively),
although the differences were not statistically significant
(p > 0.05), as is shown in Table 4.
p16 Immunostaining results
45 cases were included in the p16 analysis. From these
cases p16 was successfully performed in 40 (88.9%). In
the other 5 cases, there was no tumour in the p16 slide
(11.1%). All cases except one showed a positive p16
over-expressed pattern (Table 5). Only one case, an ade-
nocarcinoma NOS (subtype: not other specified), was
HPV negative in both fresh and paraffin embedded tis-
sue and also showed a p16 negative pattern, suggesting
that maybe it is not HPV related or it is a case with an
endometrial origin (not cervical).
Discussion
T h eg o a lo ft h i ss t u d yw a st oe x a m i n ew h e t h e rH P V
genotyping on FFPE invasive cervical carcinoma
specimens give comparable results with freshly frozen
s p e c i m e n so b t a i n e df r o mt h es a m ep a t i e n ts i m u l t a -
neously. Our study suggests that detection of HPV using
SPF10 with LiPA technology using formalin fixed paraf-
fin embedded tissues gives comparable results to freshly
frozen specimens for HPV detection in general (Kappa
index 0.26, p = 0.001), see Table 1, but is not so good
for specific HPV types detection (p-value > 0.05). Some
previous studies which compared the paraffin embedded
tissue with other samples found high agreement [7,8,11].
However, these studies used exfoliated cells or cervical
scrapes and not freshly frozen specimens. Besides, these
were cases of preneoplastic lesions, not invasive cervical
carcinoma. A study which compared FFPE tissue with
cervical scrapes from women with invasive cervical car-
cinoma found very high HPV type specific concordance
[12]. However, the number of samples studied was
small, and also the method of detection was GP5+/6+
primers.
Another interesting observation was the negative HPV
results in both freshly frozen specimens and FFPE tis-
sues. Our analysis of p16 immunostaining in samples
Table 3 HPV type distribution of multiple types in fresh
tissue versus paraffin block
Fresh tissue
a Paraffin block
b
HPV 18 & 74 HPV 18 & 74
HPV 16 & 52 HPV 16 & 52
HPV 16 HPV 16 &3 5
HPV 18 HPV 16 &18
HPV 18 HPV 18 &5 6
HPV 45 HPV 45 &5 4
HPV 16 & 45 HPV 16
HPV 18 & 31 HPV 18
HPV 18 & 70 HPV 18
HPV 59 & 74 HPV 59
HPV 39 HPV 16 &39
HPV 16 & 18 HPV 59
HPV 18 & 52 HPV 16
HPV 6 & 44 & 45 HPV 18
HPV 39 & 51 & 52 HPV 33
HPV 6 & 45 HPV negative
a Multiple HPV cases, N = 11
b Multiple HPV cases, N = 7
Table 4 HPV detection in fresh tissue versus paraffin block according to histological diagnosis
HPV detection SCC
N = 130
ADC
N=7
Number of cases % 95% CI Number of cases % 95% CI
Fresh tissue 119 91.5 (85.4-95.7) 6 85.7 (42.1-99.6)
Paraffin blocks 121 93.1 (87.3-96.8) 5 71.4 (29.0-96.3)
ADC, adenocarcinoma; CI, confidence interval; SCC, squamous cell carcinoma;
For all comparisons: p-value > 0.05
Table 5 Results of p16 expression by HPV results
HPV results fresh/paraffin
preservation
p16
- ++ +++ Total
N% N% N % N%
Concordant HPV negative 1
a 16.7 1
b 16.7 4
e 66.7 6 100
Concordant HPV positive 0 0.0 1
c 6.7 14
f 93.3 15 100
Fresh HPV positive, Paraffin
HPV negative
0 0.0 0 0.0 9
g 100 9 100
Fresh HPV negative, Paraffin
HPV positive
0 0.0 2
d 20 8
h 80 10 100
Total 1 2.5 4 10 35 87.5 40 100
p16-: < 5% stained cells; p16++: 26-75%; p16+++: > 75%
Histologies:
a adenocarcinoma NOS (not other specified)
b undifferentiated carcinoma
c undifferentiated carcinoma
d 1 adenocaricnoma and 1 undifferentiated carcinoma
e 4 squamous cell carcinoma
f 13 squamous cell carcinoma and 1 undifferentiated carcinoma
g 5 squamous cell carcinoma, 1 adenocarcinoma and 3 undifferentiated
carcinoma
h 7 squamous cell carcinoma, 1 adenocarcinoma
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sample tested p16 positive, suggesting that the cases are
HPV mediated and that the most probable reason for
not detecting the virus is related to viral, specimen pre-
servation or technical issues such as denatured DNA by
alkali [13] or by formalin fixation [14]. For specific HPV
types, if one considers fresh specimens as gold standard,
then discordance in HPV results from FFPE specimens
could be due to a number of explanations. One is that
formalin fixation could have denatured the tissue. It is
known that DNA extracted from FFPE tissues are
usually at low concentration and fragmented [14,15].
Another alternative view is reduced sensitivity detection
of some HPV types in paraffin specimens, especially
types 42, 16, 18, 39, 56, 58, 59 and 66 [16-18]. A third
possibility, which may be applicable to discordance in
multiple infections is due to competition between differ-
ent HPV genotypes [19]. It is conceivable that lower dis-
cordance rates could be obtained by reducing the
duration of fixation in buffered formalin.
The low detection of HPV in adenocarcinoma in both
types of specimens is also of interest. A number of pre-
vious studies have also found low detection of HPV in
adenocarcinoma of the cervix [9,20,21]. Plausible expla-
nations are: (a) that some cervical tumours may be of
endometrial origin and are therefore HPV negative [22];
(b) that some cervical adenocarcinomas may not be
related to HPV (such as minimal deviation adenocarci-
nomas) [21,23]; (c) low viral load; (d) fewer episomal
copies; (e) or loss of viral genome during integration in
cervical adenocarcinoma [24]. Though some investiga-
tors found a high positive rate which they attributed to
higher diagnostic accuracy and exclusion of non cervical
tumours [25].
Our results have some implications. For areas with
low resources, use of FFPE samples for HPV detection
is feasible, especially HPV testing for clinical manage-
ment of women with abnormal smears. In case a biopsy
is taken, the paraffin embedded tissue could be referred
to laboratory for HPV testing. This would make use of
HPV results, whether for prognosis or detection of pro-
gression of cervical lesionsl i k eh i g h - g r a d es q u a m o u s
intraepithelial lesion (HSIL) possible in many areas.
However, there would be a need to have standard proto-
cols so that fixation time is controlled. In some situa-
tions, the preference for fresh or paraffin tissue will
depend on the amount of available tissue and the ques-
tions being addressed.
Our study had some strengths. Compared with a
recent study which compared the use of cervical scrapes
and tissues from women with cervical carcinoma [12],
our sample size was big. The specimens were analyzed
in two different laboratories blindly using the same HPV
detection method. The SPF10 and LiPA technology are
quite sensitive and specific for HPV [16]. The study also
has, however, some limitations. The piece of tissue used
was divided in two, and half was used to prepare the
paraffin blocks and half kept as freshly frozen tissue for
HPV genotyping. Thus, they were not exactly the same
tumour materials, but pieces of tissue adjacent to each
other. Moreover, a small number of adenocarcinomas
limits the use of statistical tests.
Conclusions
There were no differences in HPV positivity between
freshly frozen tissue and paraffin embedded tissue in
general, but for specific types, only 65% of the cases had
complete or partial agreement on the HPV detection.
HPV DNA detection was lower in ADC as compared to
SCC, the difference being higher in paraffin blocks than
in fresh tissue (21 percentage points difference versus 6,
respectively; p > 0.05). However, such differences were
minimized when additional p16 testing was added, sug-
gesting that technical issues largely explain the HPV
negative cases.
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